Trial Profile
A monocentric retrospective study evaluating benefit of cetuximab addition to a platinum-fluorouracil-based chemotherapy in metastatic head and neck cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2017
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- 13 Oct 2017 New trial record
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress